-William E Boeglin Researcher Activity Profile

Research Author Detailed Information 

William E Boeglin Publication Rate By Year

William E Boeglin has published 3 paper(s) in 2006, 9 paper(s) in 2007, 1 paper(s) in 2008, for a total of 13 research publications in total.

William E We Boeglin Author Information

LAST NAME: boeglin

FIRST NAME: William E

INITIALS: we

AFFILIATION:

Papers

William E Boeglin's Publication Record

1. Demonstration of ubiquitin thiolester formation of UBE2Q2 (UBCi), a novel ubiquitin-conjugating enzyme with implantation site-specific expression. Year Published: 2006
Department of Obstetrics and Gynecology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. mike.melner@vanderbilt.edu
2. Human and mouse eLOX3 have distinct substrate specificities: implications for their linkage with lipoxygenases in skin. Year Published: 2006
Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
3. Epidermal lipoxygenase products of the hepoxilin pathway selectively activate the nuclear receptor PPARalpha. Year Published: 2007
Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University School of Medicine, 23rd Ave. at Pierce, Nashville, TN 37232-6602, USA.
4. The hepoxilin connection in the epidermis. Year Published: 2007
Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232-6602, USA. alan.brash@vanderbilt.edu
5. A mouse mutation in the 12R-lipoxygenase, Alox12b, disrupts formation of the epidermal permeability barrier. Year Published: 2007
Genetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. jmoran@rics.bwh.harvard.edu
6. A critical role of non-active site residues on cyclooxygenase helices 5 and 6 in the control of prostaglandin stereochemistry at carbon 15. Year Published: 2007
Department of Chemistry, Tallinn University of Technology, Akadeemia tee 15, Tallinn 12618, Estonia.
7. Enzymatic synthesis of a bicyclobutane fatty acid by a hemoprotein lipoxygenase fusion protein from the cyanobacterium Anabaena PCC 7120. Year Published: 2007
Department of Pharmacology, Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
8. Enantiomeric separation of hydroxy and hydroperoxy eicosanoids by chiral column chromatography. Year Published: 2007
Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
9. Epidermal lipoxygenase products of the hepoxilin pathway selectively activate the nuclear receptor PPARalpha. Year Published: 2007
Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University School of Medicine, 23rd Ave. at Pierce, Nashville, TN 37232-6602, USA.
10. Enantiomeric separation of hydroxy and hydroperoxy eicosanoids by chiral column chromatography. Year Published: 2007
Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
11. Enzymatic synthesis of a bicyclobutane fatty acid by a hemoprotein lipoxygenase fusion protein from the cyanobacterium Anabaena PCC 7120. Year Published: 2007
Department of Pharmacology, Vanderbilt Institute of Chemical Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
12. Convergent oxygenation of arachidonic acid by 5-lipoxygenase and cyclooxygenase-2. Year Published: 2006
Department of Pharmacology, Division of Clinical Pharmacology, 23rd Avenue South at Pierce, Vanderbilt University Medical School, Nashville, Tennessee 37232, USA. claus.schneider@vanderbilt.edu
13. A 49-kDa Mini-lipoxygenase from Anabaena sp. PCC 7120 Retains Catalytically Complete Functionality. Year Published: 2008
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.